Abstract:Patients with chronic obstructive pulmonary disease (COPD) are characterized by a variety of comorbid conditions, including both somatic (arterial hypertension, atherosclerosis, coronary heart disease, bronchial asthma, malignant neoplasms, diabetes mellitus, obesity, etc.) and mental (depressive disorders, suicide attempts). Against the background of various chronic diseases of the respiratory system, endocrine, metabolic disorders, the risks of exacerbations of COPD increase. The leading unifying mechanism of these conditions is systemic subclinical inflammation. Its excessive activity leads to the loss of the physiological functions of inflammation, which is accompanied by an imbalance in the endocrine system and the release of high concentrations of hormones and neurotransmitters. The result of this response is the uncoupling of cytokine mechanisms, which leads to an imbalance in the system of pro- and anti-inflammatory cytokines. The article describes the role of the pro-inflammatory chemokine IL-8 (interleukin 8), which is responsible for the migration of neutrophils to the site of inflammation. This is how the neutrophilic type of inflammation is formed. IL-4 and IL-10 are considered, which occupy a leading position in the formation of CD4+ type of immunoreactivity, which is observed in bronchial asthma. Attention is focused on the significance of IL-6, because it is an integral component of local and systemic inflammation. An increase in its concentration and, as a result, a potential risk of damage to the respiratory epithelium is the remodeling of the bronchial tree, resulting in a decrease in the elasticity of the epithelium of the respiratory tract. This mechanism leads to the formation of pulmonary emphysema and further potentiation of pathophysiological processes in patients with COPD. Since IL-6 is a cytokine with anti-inflammatory properties, its molecular activity is achieved by interacting with a special receptor complex consisting of two subunits: IL-6R and gp130. The former mediates IL-6 binding, while the latter triggers the JAK/STAT or MAPK signaling cascade pathways. The result of the reaction of IL-6 with the effector cell directly depends on the type of signaling. The paper describes three mechanisms of signal transduction into the target cell: classical, cluster, and transsignaling. Thus, by studying the role of cytokines in the systemic inflammatory response, we have shown the cross-talk between adipose tissue and the lungs in obesity, highlighting the main inflammatory mediators, which may indicate new therapeutic targets for preventing pulmonary dysfunction.

Biomarkers of systemic inflammation in pathogenesis of syntropic occupational bronchial asthma and metabolic syndrome

Biomarkers of Oxidative Stress and Inflammation in Chronic Airway Diseases

Prognostic role of novel inflammatory biomarkers in patients with chronic obstructive pulmonary disease with metabolic syndrome

Pathophysiological relation between the systemic inflammation and the state of small airways in mild asthma with obesity

Genetic-biochemical criteria for individual sensitivity in development of occupational bronchopulmonary diseases

The role of cytokines in the development of systemic inflammation in chronic obstructive pulmonary disease and obesity

Clinical utilization of airway inflammatory biomarkers in the prediction and monitoring of clinical outcomes in patients with chronic obstructive pulmonary disease

Biomarkers in asthma, potential for therapeutic intervention

Potential New Inflammatory Markers in Bronchiectasis: A Literature Review

Alterations of Plasma Inflammatory Biomarkers in the Healthy and Chronic Obstructive Pulmonary Disease Patients with or Without Acute Exacerbation.

Emergent Inflammatory Markers and Echocardiographic Indices in Patients with Bronchial Asthma

Characterization of sputum biomarkers for asthma–COPD overlap syndrome

Biomarkers of oxidative stress in acute and chronic bronchial asthma

Noninvasive Markers of Airway Inflammation in Asthma

The cytokine level in exhaled breath condensate and cytokine genes polymorphism in children with bronchial asthma

Allergic asthma biomarkers using systems approaches

Selection of Disease-Specific Biomarkers by Integrating Inflammatory Mediators with Clinical Informatics in Patients with Aecopd: A Preliminary Study

A Systemic Inflammatory Endotype Of Asthma With More Severe Disease Identified By Unbiased Clustering Of The Serum Cytokine Profile

Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer

Genetic polymorphisms of IL6, IL10, TNF-a and IL4R and associations with the risk of chronic obstructive pulmonary disease in a sample of Belarusian population

Biomarkers of type 2 and non-type 2 inflammation in asthma exacerbations